维普中文期刊产品整合服务
652篇 您的检索式:作者名="Dowsett"
    题名 作者 年代 出处 被引量
1Sphincter of Oddi dysfunction:Psychosocial distress correlates with manometric dyskinesia but not stenosis显示文摘AIM:To compare postcholecystectomy patients with Sphincter of Oddi(SO)dyskinesia and those with normal SO motility to determine the psychosocial distress,gender and objective clinical correlates of dyskinesia,and contrast these findings with comparisons between SO stenosis and normal SO motility.METHODS:Within a cohort of seventy-two consecutive postcholecystectomy patients with suspected SO dysfunction,manometric assessment identified subgroups with SO dyskinesia(n=33),SO stenosis(n=18)and normal SO motility(n=21).Each patient was categorized in terms of Milwaukee Type,sociodemographic status and the severity of stress-coping experiences.RESULTS:Logistic regression revealed that in combination certain psychological,sociodemographic and clinical variables significantly differentiated SO dyskinesia,but not SO stenosis,from normal SO function.Levels of psychosocial stress and of coping with this stress(i.e.anger suppressed more frequently and the use of significantly more psychological coping strategies)were highest among patients with SO dyskinesia,especially women.Higher levels of neuroticism(the tendency to stressproneness)further increased the likelihood of SO dyskinesia.CONCLUSION:A motility disturbance related to psychosocial distress may help to explain the finding of SO dyskinesia in some postcholecystectomy patients.Ethelle Bennett Peter Evans John Dowsett John Kellow 2009World Journal of Gastroenterology2009,15,48:4
2Complications of sphincter of Oddi manometry: biliary-like pain versus acute pancreatitis 显示文摘Wong GS Teoh N Dowsett JD 2005Scand J Gastroenterol2005,40,2:1
3Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oestrogen receptor,progesterone receptor,EGF receptor and HER2 status显示文摘Dowsett M Houghton J Iden C 2006Ann Oncol2006,17,5:1
4Recommendations for HER-2 testing in the UK显示文摘Ellis IO Dowsett M Bartlett J 2000J Clin Pathol2000,53,12:1
52-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial显示文摘Ian Smith Marion Procter Richard D Gelber Sébastien Guillaume Andrea Feyereislova Mitch Dowsett Aron Goldhirsch Michael Untch Gabriella Mariani Jose Baselga Manfred Kaufmann David Cameron Richard Bell Jonas Bergh Robert Coleman Andrew Wardley Nadia Harbec 2007The Lancet2007,,9555:1
6Massive ocerdose with eonrtolled-release earbazepine resulting in delayed peak serum concentrations and life-threateing显示文摘GRAUDINS A PEDEN G DOWSETT RP 2002Emorg Med2002,14,1:1
7Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrnzole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial显示文摘Smith IE Dowsett M Ebbs SR 2005J Clin Oncol2005,23,22:1
8Benefit from adjuvant tamoxifen therapy in primary breast cancer patients according oes- trogen receptor, progesterone receptor, EGF receptor and HELL2 status显示文摘Dowsett M Houghton J Iden C 2006Ann Oncol2006,17,5:1
9Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer显示文摘Dowsett M 2001Endocrine-related Cancer2001,8,3:1
10American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version) 显示文摘Hammond MEH Hayes DF Dowsett M 2010Arch Pathol Lab Med2010,134,7:1
11Neoadjuvant endocrine therapy:Patient selection, treatment duration and surrogate endpoints 显示文摘Yeo B Dowsett M 2015Breast2015,24,2:1
12Retrospective analysis of time to recurrence in the ATAC trial according to hormone receptor status:an hypothesis-generating study显示文摘Dowsett M Cuzick J Wale C 2005J Clin Oncol2005,23,30:1
13Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction 显示文摘Smith A C Dowsett J F Russell R C 1994Lancet1994,344,8938:1
14Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastroz, ole, Tamoxifen, or Combined with Tamoxifen (IMPACT)multicenter double-blind randomized trial 显示文摘Smith IE Dowsett M Ebbs SR 2005J Clin Oncol2005,23,22:1
15Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men 显示文摘Khaw KT Dowsett M Folkerd E 2007Circulation2007,116,23:1
16Meta-analysis of breast cancer outcomes in adjuvant trials of aro- matase inhibitors versus tamox- ifen显示文摘Dowsett M Cuzick J Ingle J 2009J Clin Oncol2009,28,3:1
17HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer显示文摘Dowsett M Harper- Wynne C Boeddinghaus I 2001Cancer Res2001,61,23:1
18A 'quickscore' method for immunohistochemical semiquantitation: vali- dation for oestrogen receptor in brest carcimomas显示文摘Detre S Saclani J G Dowsett M 1995J Clin Pathol1995,48,9:1
19American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer显示文摘Hammond M E Hayes D F Dowsett M 2010J Clin Oncol2010,28,16:1
20American Society of Clinical Oneology/College Of American Pathologists guideline rec- ommendations for immunohistochemieal testing of estrogen and pro- gesterone receptors in breast cancer 显示文摘Hammond ME Hayes DF Dowsett M 2010J Clin Onco2010,28,16:1
返回顶部 每页显示:
共33页 首页 上一页 第1页 下一页 末页 /33 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费